Detalles de la búsqueda
1.
Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis.
J Formos Med Assoc
; 121(10): 2123-2129, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35570052
2.
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.
Oncologist
; 25(5): e782-e788, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31852810
3.
Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice.
Int J Mol Sci
; 21(20)2020 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33076306
4.
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study.
Support Care Cancer
; 27(5): 1663-1672, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30112724
5.
MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
BMC Cancer
; 14: 809, 2014 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25369863
6.
Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.
Sci Rep
; 14(1): 6161, 2024 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485750
7.
Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies.
J Clin Med
; 12(17)2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685720
8.
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer.
Biomedicines
; 11(3)2023 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979671
9.
The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort.
Biomedicines
; 11(12)2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38137334
10.
High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach.
Cancers (Basel)
; 15(16)2023 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627178
11.
Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor Response.
Clin Cancer Res
; 28(8): 1479-1481, 2022 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121621
12.
Bispecific antibodies in multiple myeloma treatment: A journey in progress.
Front Oncol
; 12: 1032775, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36330495
13.
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.
Blood Cancer J
; 12(8): 118, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973981
14.
Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area.
J Fungi (Basel)
; 8(4)2022 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35448639
15.
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan.
J Pers Med
; 12(2)2022 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35207619
16.
Is it reasonable for the use of Rh-ee blood? A hospital-based survey from a southern medical center in Taiwan.
Kaohsiung J Med Sci
; 38(1): 65-69, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34647681
17.
Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy.
Biomedicines
; 10(7)2022 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884943
18.
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma.
Cancers (Basel)
; 13(23)2021 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34885245
19.
Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma.
Biomed Res Int
; 2021: 3291762, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34631879
20.
Progression Risk Score Estimation Based on Immunostaining Data in Oral Cancer Using Unsupervised Hierarchical Clustering Analysis: A Retrospective Study in Taiwan.
J Pers Med
; 11(9)2021 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34575686